Literature DB >> 35135436

Acceptance and forgiveness therapy for veterans with moral injury: spiritual and psychological collaboration in group treatment.

Patricia U Pernicano1, Jennifer Wortmann2, Kerry Haynes1.   

Abstract

The authors developed Acceptance and Forgiveness Therapy (AFT), a psychospiritual group intervention that guides veterans with moral injury experientially from a trauma-focused (damaged, broken, guilty, unforgivable, hopeless, unacceptable) to restorative (worthy, connected, hopeful, forgiven, responsible) view of self. A mental health (MH)-trained chaplain and MH provider, as co-leaders, provide psychoeducation, facilitate therapeutic interaction, and encourage home practice. The curriculum includes evidence-driven psychological interventions, spiritually oriented practices, and metaphor, story, and art to illustrate concepts and facilitate self-expression. Scores on the Brief Symptom Inventory-18 and Acceptance and Action Questionnaire-2 showed decreased distress and increased flexibility. Post-group drawings reflect renewed purpose, greater self-acceptance, and meaningful engagement with others. Retention rate across seven group administrations ranged from 50% to 100%. Outcomes suggest AFT is a promising practice for veteran moral injury meriting further study and implementation.

Entities:  

Keywords:  Moral injury; chaplain; group; psychospiritual; veteran

Mesh:

Year:  2022        PMID: 35135436     DOI: 10.1080/08854726.2022.2032982

Source DB:  PubMed          Journal:  J Health Care Chaplain        ISSN: 0885-4726


  2 in total

1.  The Moral Injury Experience Wheel: An Instrument for Identifying Moral Emotions and Conceptualizing the Mechanisms of Moral Injury.

Authors:  Wesley H Fleming
Journal:  J Relig Health       Date:  2022-10-12

2.  Forgiveness: A Key Component of Healing From Moral Injury?

Authors:  Suzette Brémault-Phillips; Terry Cherwick; Lorraine Alison Smith-MacDonald; John Huh; Eric Vermetten
Journal:  Front Psychiatry       Date:  2022-07-13       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.